A pioneering hormone-free contraceptive pill for men is showing promising results in preliminary human trials, according to developers at YourChoice Therapeutics. The pill, named YCT-529, operates by disrupting vitamin A pathways necessary for sperm development, offering reversible infertility as tested in mammal studies.
About the Author
